{'text': "FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia", 'publisher': {'href': 'https://www.prnewswire.com', 'title': 'PR Newswire'}, 'created_at': 'Tue, 09 Jun 2015 07:00:00 GMT', 'description': "FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia  PR Newswire", 'url': 'https://news.google.com/rss/articles/CBMinAJBVV95cUxQVmZfR01RUjE4aENEMVhLS0p1bzlZNVNMN2pPMDRqRlpoRlpybGhmVEx3YzVqdnI1QUpySEY1bEFGSV94Vng2RkZjbjU5aFFFdW9nNzRvZV91VjdYVTVSTVQxVmt4RjhSckt4ZC1icE9ReEVISUxzSjdQMkljUkVCZS1LZVhfcm5MUzJ0aEVYLThtUXh2VlJ1ZEt1OTB1aUxGRVhyLWd3QmtISHJQN1hISWNNWUttMmJTVVVmbGtjR19OWFlGN2dYY3lmWXc2bTVSSGU3cWtXSnpOa0tkbk14bm5CTUktWTE2OE5POGh6QUxnVTVjcURhN0JaR2tMMmh1ODgtMVIxcDZDRkllMWpSRGdHUG9BcnM2eFk2Rg?oc=5&hl=en-US&gl=US&ceid=US:en'}
